North America Radiotherapy Market – Industry Trends and Forecast to 2024 | Data Bridge Market Research - Data Bridge Market Research

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email

North America Radiotherapy Market – Industry Trends and Forecast to 2024

Reports

North America Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024

$2,500.00
Clear selection

The North America Radiotherapy Market has accounted for USD 2.2 billion in 2016, and is expected to reach USD 3.5 billion by 2024, growing at a CAGR 5.8% during the forecast period 2017 to 2024.The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumors and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumors that cause metastasis. In current healthcare scenario localized treatment of tumors the only efficient treatment for tumors. Radiosurgery is used alongside surgery or separately to treat cancer for a long time. More than 75% of the cancer patient population is expected to take radiosurgery in some point of their disease prognosis.

There has been rapid development in the radiosurgery field in recent years, owing to increased threat of multiple cancers and mortality. This has allowed pulling in large government and healthcare manufacturers funding’s in research labs developing treatment and preventive techniques against cancer. The Elekta gamma knife has completed more than 1 million surgeries as announced by Elekta in May 2016. This shows the demand of radiotherapy products, and the requirement of disruptive technologies to change to modern day radiotherapy. According to Hospital Cost and Utilization Project (HCUP) the number of radiotherapy procedures is increasing in U.S. by 2.0% every year.

The North America radiotherapy market is segmented based on therapy, product, application and geography. Based on the therapy, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy. On the basis of radiations delivered, the external beam radiotherapy is sub segmented into intensity-modulated radiation therapy (IMRT), image guided radiotherapy (IGRT), tomotherapy, stereotactic technology, 3D conformal radiotherapy, proton beam therapy, and volumetric modulated arc therapy (VMAT). The IGRT segment is expected to account for the largest share of the external beam radiotherapy market, whereas the VMAT segment is poised to witness the highest growth. Based on the delivery of dose-rate, the internal beam therapy is divided into low (LDR) and high-dose rate (HDR). The LDR segment is expected to account for the largest share of the internal radiotherapy/brachytherapy market, whereas the HDR segment is poised to witness the highest growth.

Based on product type the North America radiotherapy market is segmented into EBRT equipment’s, and IBRT equipment’s. The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron). The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.

The North America radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.

Based on geography the North America radiotherapy market is segmented into 3 countries, U.S., Canada and Mexico. U.S. is expected to dominate the market due to rising incidence of cancer, most advanced technologies, and complete healthcare coverage.

The market is highly fragmented based on technologies offered by different manufacturers are different. The major players are concentrating on product development and strategic mergers with healthcare payers and providers to penetrate the market. The major players in the North America radiotherapy market are Varian Medical Systems, Inc., CIVCO Medical Solutions, Elekta AB, Nanobiotix, Accuray Incorporated, Brainlab AG, Ion Beam Applications SA, C. R. Bard, Inc., IsoRay Medical, Inc., TRF, Nordion, Inc., RaySearch Laboratories AB, PRECISIS AG, Mevion Medical Systems, Inc., and Mitsubishi Electric Corporation among other player

Share this!
Choose Licence Type

Enterprise, Single User

Available on Request.

Thank You

Share this!

Thank You

Share this!

Please fill in the below form and our sales representatives will get back to you.

Thank You

Share this!
`
Show Buttons
Hide Buttons